“…Cell lysates, supernatant fractions, and pellet fractions were then either mixed with SDS sample buffer (Laemmli, 1970) and subjected to SDS-PAGE and immunoblot analyses, or supplemented with 1% SDS and 5 mM EDTA, diluted 1:10 in immunoprecipitation buffer (50 mM Tris/ HCl, pH 8.0, 150 mM NaCl, 1% Triton X-100, 5 mM EDTA), and processed for immunoprecipitation. One milliliter samples were incubated with 100 p.l protein A-Sepharose (Pharmacia Biotech, Brussels, Belgium; 10% (w/v) in immunoprecipitation buffer) for 1 h, briefly centrifuged in an Eppendorf centrifuge, and supernatants were incubated with 10 p.l of plectin antiserum (Wiche and Baker, 1982), or with 10 ,ug/ml purified monoclonal antibodies to c-myc (Evan et al, 1985;ATCC CRL 1229), or with 100 p.l of Sepharose beads coupled to monoclonal antibody to plectin 7A8 (0.25 mg/ml beads; Foisner et al, 1991aFoisner et al, , 1994 or to the myc antibody (1-2 mg/ml) overnight at 4°C. After addition of 10% protein A Sepharose to the former two samples and 4 h of incubation, all samples were centrifuged for 5 min in an Eppendorf centrifuge and pellets were washed three times in immunoprecipitation buffer and solubilized in SDS-PAGE sample buffer (Laemmli, 1970).…”